key: cord-0695941-4u2rpf7c
authors: Keihanian, Tara; Sharma, Prateek; Goyal, Jatinder; Sussman, Daniel A.; Girotra, Mohit
title: TeleHealth utilization in Gastroenterology (GI) clinics amid Coronavirus-19 (COVID-19) pandemic: Impact on clinical practice & GI training
date: 2020-06-20
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.06.040
sha: 60bd9816ed49d8fc537d73dc9f2329ec91a6ee41
doc_id: 695941
cord_uid: 4u2rpf7c

nan

The Centers for Medicare & Medicaid Services (CMS) defines TeleHealth as services including office visits/consultations, delivered remotely by an eligible provider, using an interactive 2-way telecommunications system (audio+video). 1 Prior to COVID-19, CMS paid for TeleHealth restrictively; however, emergence of the COVID-19 pandemic resulted in Waiver-1135, extending these services to routine healthcare, to keep vulnerable beneficiaries in their homes, limit community viral spread, and prevent exposure to other patients and staff. 1 This benefit was reciprocated by private insurance carriers. While these changes provided healthcare facilities an opportunity to rapidly adopt the remote healthcare delivery model, the uptake and challenges accompanying this practice change are largely unknown.

We conducted a survey to assess the impact of TeleHealth adoption on clinical practice and GI training programs.

A web-based survey was disseminated amongst gastroenterology/hepatology providers (attending physicians, fellows, nurse practitioners, physician assistants), via en masse emails, social media promotion and direct contact by authors. The survey consisted of 50 questions pertaining to adoption, utilization and barriers to TeleHealth, and its impact on GI fellow education. Detailed methodology is provided in Appendix.

230 respondents (71.7% physicians, 21.3% fellows, 7.4% physician extenders) completed the survey, with 67.8% responses from academic settings.

During COVID era, average weekly half-day clinics for GI physicians increased (3.18±1.85 to 3.44±2.38;p=0.14), but average number of patients visits dropped (10.28±4.48 to 6.51±4.28;p<0.001).

229/230 (99.6%) respondents confirmed adoption of varying degrees of TeleHealth in their clinical model, with 58.0±32.5% TeleHealth (via-video), 33.2±30.5% TeleMedicine (viaphone) and 10.5±17.8% in-person visits. During this change, patient show-rate increased for 36.7% and decreased for 18.1% respondents, and 45.4% reported decrease in productivity. With inconsistent clinical support, 50.4% providers felt abandoned with heightened responsibilities with TeleHealth.

From a provider perspective, ability to have face-to-face interaction (88.3%), patient trust/satisfaction (57.3%) and sharing screen/image (38%) were the foremost reasons for preferring video over phone visits. 82.4% respondents noted that phone was convenient for less technologically inclined populations and had fewer HIPAA concerns (10.7%). 53.5% physicians considered level of reimbursement a determining factor.

TeleHealth barriers included technical issues with platform/WiFi/internet connectivity (67.0%) and lack of patient preparedness (42.1%), while the main benefit was less personal exposure to COVID-19 (83.9%).

95.2% respondents foresee a valuable role for TeleHealth in GI beyond the pandemic and wanting to continue if adequately reimbursed. 80.4% agreed that institutional advantages (decreased infrastructural cost for clinic space and clinic staff) may favor its adoption and 87.5% believed it could increase access to GI subspecialists.

In GI attending clinics, fellow participation dropped to less than 50% with adoption of TeleHealth, and main barriers included challenges with discussing fellows' assessment/plan before sharing with patient (48.8%), lack of educational time (48.0%) and shorter clinic appointment times (44.0%).

GI fellows' continuity clinics became 'virtual' for 90% respondents (39% via-video; 51% via-phone), while in-person visits continued for 21% in a hybrid model. A supervising attending was concurrently involved throughout in only 11.8%, participating for a portion of time in 39.2%, while in 23.5%, the fellow completed the virtual clinic and discussed cases/plans with attending at a later time. 63% fellows acknowledged having a dedicated discussion time with faculty at the end of each virtual visit or entire clinic session. With these changes, 34.5% fellows noted a compromise in outpatient GI educational mission with adoption of TeleHealth.

Respondents from academic centers reported significantly higher use of TeleMedicine (via-phone) (35.8±29.3%vs.25.3±26.1%; p=0.012), while in-person visits were significantly higher in non-academic settings (15.7±24.5%vs.8.7±14%; p=0.008). Use of TeleHealth (viavideo) was not significantly different between the two settings (56.7± 30.5%vs.58.1±31.5%; p=0.75).

With respect to geographic variation, use of TeleHealth (via-video) was not significantly different across different regions, although West reported highest mean percentage use. While NorthEast region reported significantly higher TeleMedicine (via-phone) use (vs. SouthEast, p=0.005 or West, p=0.004), SouthEast had significantly higher in-person visits than NorthEast (p<0.001). West region also reported a significantly higher dedicated time for new patient encounters (vs. SouthEast; p=0.029) and follow-up encounters (vs. SouthEast; p=0.024 and NorthEast; p=0.012). Detailed analysis is provided in table-1.

NorthEast respondents were inclined towards TeleMedicine (via-phone) over TeleHealth (via-video), compared to SouthEast region, for reasons including less technically inclined population, less platform connectivity burden and fewer privacy concerns.

Ours is the first study from United States providing a comprehensive snapshot focusing singularly on TeleHealth in GI, in response to COVID-19.

Our survey suggests almost universal adoption of TeleHealth, with 87.9% of 165 physicians reporting >75% utilization in their centers, an increase compared to a recent report where 47% centers implemented >75% TeleHealth. 2 We also observe a noteworthy variation in utilization of TeleHealth by region and practice type. This variability might be a reflection of regional influences (higher COVID-19 disease prevalence in NorthEast and fewer technologically inclined populations in SouthEast). Alternatively, private practice settings may have been poised for a more rapid transition to the economically more desirable TeleHealth (viavideo) than academic centers. Our results also demonstrate high utilization of TeleHealth in GI fellows clinic (90%), but further insight from fellows reveals that training has suffered significantly with this platform, given lack of consistent supervision in fellows' continuity clinics, and decreased participation in attending clinics 3 .

Although our overall responses are modest (n=230), the survey has strong geographic representation (32 states), with an almost equal mix of academic and community centers. The survey was disseminated in late May, to ensure providers had adequate time to adapt to TeleHealth utilization and to sufficiently recognize its benefits/barriers. While TeleHealth in GI has been almost universally adopted, the manner of incorporation into individual GI practices and training environments has been varied. While the majority (95.2%) of responders recognize its valuable role beyond the pandemic, many centers (20.6%) plan to completely transition to in-person visits as the country re-opens, due to the aforementioned barriers 4-6 . Efficient methods are needed to deliver high-quality patient-centered TeleHealth-care that involves trainees, addressing systemic challenges to what both providers and patients recognize must be a part of the future of health delivery.

North American Alliance for the Study of Digestive Manifestations of COVID-19

NASPGHAN Training Committee COVID-19 Survey Working Group. Impact of COVID-19 on Pediatric Gastroenterology Fellow Training in North America

Epub ahead of print

The telehealth skills, training, and implementation project: an evaluation protocol

Identifying perceived barriers to videoconferencing by rehabilitation medicine providers

Telehealth In Health Centers: Key Adoption Factors, Barriers, And Opportunities

* 1 respondent did not specify region $ using Independent sample T test # using one way ANOVA with Tukey's post-hoc @ using one way ANOVA with Games Howell post-hoc